These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9095355

  • 1. Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Barrett JA, Crocker AC, Damphousse DJ, Heminway SJ, Liu S, Edwards DS, Lazewatsky JL, Kagan M, Mazaika TJ, Carroll TR.
    Bioconjug Chem; 1997; 8(2):155-60. PubMed ID: 9095355
    [Abstract] [Full Text] [Related]

  • 2. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR.
    Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
    [Abstract] [Full Text] [Related]

  • 3. Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugates.
    Barrett JA, Damphousse DJ, Heminway SJ, Liu S, Edwards DS, Looby RJ, Carroll TR.
    Bioconjug Chem; 1996; 7(2):203-8. PubMed ID: 8983342
    [Abstract] [Full Text] [Related]

  • 4. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.
    Liu S, Edwards DS, Harris AR.
    Bioconjug Chem; 1998; 9(5):583-95. PubMed ID: 9736492
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.
    Lister-James J, Vallabhajosula S, Moyer BR, Pearson DA, McBride BJ, De Rosch MA, Bush LR, Machac J, Dean RT.
    J Nucl Med; 1997 Jan; 38(1):105-11. PubMed ID: 8998163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.
    Lister-James J, Knight LC, Maurer AH, Bush LR, Moyer BR, Dean RT.
    J Nucl Med; 1996 May; 37(5):775-81. PubMed ID: 8965144
    [Abstract] [Full Text] [Related]

  • 9. Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom.
    Knight LC, Baidoo KE, Romano JE, Gabriel JL, Maurer AH.
    J Nucl Med; 2000 Jun; 41(6):1056-64. PubMed ID: 10855635
    [Abstract] [Full Text] [Related]

  • 10. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
    Pearson DA, Lister-James, McBride WJ, Wilson DM, Martel LJ, Civitello ER, Dean RT.
    J Med Chem; 1996 Mar 29; 39(7):1372-82. PubMed ID: 8691467
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model.
    Knight LC, Maurer AH, Romano JE.
    J Nucl Med; 1996 Mar 29; 37(3):476-82. PubMed ID: 8772651
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets.
    Knight LC, Radcliffe R, Maurer AH, Rodwell JD, Alvarez VL.
    J Nucl Med; 1994 Feb 29; 35(2):282-8. PubMed ID: 8295000
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.
    Fang W, He J, Kim YS, Zhou Y, Liu S.
    Bioconjug Chem; 2011 Aug 17; 22(8):1715-22. PubMed ID: 21780818
    [Abstract] [Full Text] [Related]

  • 18. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.
    Klem JA, Schaffer JV, Crane PD, Barrett JA, Henry GA, Canestri L, Ezekowitz MD.
    J Nucl Cardiol; 2000 Aug 17; 7(4):359-64. PubMed ID: 10958278
    [Abstract] [Full Text] [Related]

  • 19. In vitro platelet binding compared with in vivo thrombus imaging using alpha(IIb)beta3-targeted radioligands.
    Knight LC, Romano JE, Maurer AH.
    Thromb Haemost; 1998 Nov 17; 80(5):845-51. PubMed ID: 9843182
    [Abstract] [Full Text] [Related]

  • 20. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
    Ono M, Arano Y, Mukai T, Saga T, Fujioka Y, Ogawa K, Kawashima H, Konishi J, Saji H.
    Bioconjug Chem; 2002 Nov 17; 13(3):491-501. PubMed ID: 12009938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.